Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry All he said was see my reply on Twitter, it say Wednesday but nothing else. Look back a few post you can see what he replied and the twitter post I linked . GLTA
If you go back and listen to that podcast a few times , he starts to speak on a subject or answers the question then stops himself and rethinks how to word the answers. Many things he talks about are already finished and waiting on the deals to be finialized. This was around the same time he was getting the muzzle put on by CC., and shortly after silence was the norm. Again I believe EU and Africa are further than they are leading on at this point.IMO
Hopefully he will with details, truthful forecast. Why not talk directly to the shareholders first by way of a news letter, not some paid EGC call I believe the shareholders are due that respect. Would he have even be doing this EGC if people have been sending in their questions and concerns? I sent a few in with very direct questions and a copy of the SEC form filled out. Did that provoke him to feel the need to speak all of the sudden or someone elses questions we won't know but something did. No news out about appearing on upcoming EGC. I am using his own words here that you can look at 2 ways. He states future financing and potential uplisting , both of thoses words are wishful thinking for something to happen. Definition of potential as an adjective having or showing the capacity to become or develop into something in the future:
"a two-pronged campaign to woo potential customers"
as a noun latent qualities or abilities that may be developed and lead to future success or usefulness:
"a young broadcaster with great potential" · "the potentials of the technology were never wholly controllable"
Basically he is using vague words ( and that is what the safe harbor statements are for maybe one day this might happen), but for the ones that bought in thinking it was going to be a lot sooner than later this stings. Share counts is where you make the money, you dont make them on small share count in the OTC.
The wow factor is using a .02 buy in for a million shares 20k investment , R/S now you have 667 shares. That person would need 29.98 a share to break even, at .01 it is a SP 14.99. That is not happening anytime soon if ever. It is a hard decision that many are looking at now. The ones who got in earlier great but this company will not have a SP to help anyone that got in over a .01 or averaged down to .01 to breakeven for years if then. Just like when he was asked about a buy out amount and he said a Billion at current 5 Billion share count that would be .20 cents We all would love that. I am just stating the facts and the numbers it is for each to see for themselves and decide how to countinue with this gamble.Hopefully he has a better way of communicating this R/S , the reasons and judgifications with facts not I hope we get better finiancing and potential uplistings. A big question is where is Lilly in on this from 2016 dealings. Another big question is he in the near future going to issue himself a newly created class of shares bet he doesnt answer that..IMO GLTA
https://twitter.com/TheRegenBio
Regen BioPharma Inc.
@TheRegenBio
·
1h
$RGBP $RGBPP
Next Wednesday I'll be addressing the reverse split, future financing and potential uplisting on the Emerging Growth Conference. Please email me any questions you want addressed on the above topics. Also, time permitting, I will take questions from the audience.
Here is question I sent in and his reply . Can someone post his Twitter post. Dont have Twitter. Thank you
My reply to him
Thank you for the response will post on IHub so the word can get out . I don’t have twitter but will find away.
To: alan Cc: David.Koos@regenbiopharma.com
David Koos<venturebridge@gmail.com
5:00 PM
Please review Twitter post
On Monday, February 13, 2023, wrote:
Hey David
Can you answer this question ,
How do you think you are going to up list to NASDAQ as you stated in a public video that is fraud when you deceive your shareholders.
There is one area that will keep this stock off any big board-net loss. No board will let you uplist if you have a net loss 3 years prior to application. This company most recent net loss year was 9/30/21-$6 million net loss. Wont be able to apply based on that until 9/30/24.
They have been working on it for awhile, what would be nice is if they are using Enzolytics now maybe it can pass thru the testing quicker since they have approval for one already. GLTA
https://www.verywellhealth.com/fda-approves-first-ebola-treatment-regeneron-5082609
Speedy recovery Cat .
I hope your right GLTA
Crickets? Hope you read some of the requirements , or maybe just read the one that is on the board mate. If he follows thru with R/S after a public video stating his plan to uplist it is called fraud to his shareholders. The truth is in the details
Thank you for pointing out just one of the reason.
No problem mate, I want this to work 10 million times over, but R/S are not good never seen one in OTC workout for the investor have you here in the OTC?
That would be nice, but if he sold all the company buying would want is to make sure all the approved patents and filed for patents are theirs and all the other companies become theirs also unless noted not to be in deal. The buyout would be for ( X ) amount , whether it is for 5.8 billion shares or R/S ratio would still work out the same based on an agreed price per share
I posted a link awhile back ,
Item 5.03 Amendments to Articles of Incorporation
On February 6, 2023 Regen Biopharma, Inc. (the “Company”) filed with the Nevada Secretary of State
(a) An amendment to the Certificate of Designations of the Company’s Series AA Preferred Stock reducing that number of votes per share of Series AA Preferred stock to seven votes per share as of March 6, 2023.
(b) An amendment to the Certificate of Designations of the Company’s Series NC Preferred Stock reducing that number of votes per share of Series NC Preferred stock to three hundred and thirty four votes per share as of March 6, 2023
(c) A Certificate of Change authorizing 1 for 1500 reverse stock split of all issued series of stock. One share of Common Stock will be issued after the exchange for one thousand five hundred shares of Common Stock issued. One share of each series of Preferred Stock will be issued after the exchange for one thousand five hundred shares of each series of Preferred Stock issued. The reverse stock split shall become effective March 6, 2023.
Am I missing where it say ( I ) Might do a R/S , I read it as The reverse stock split shall become effective March 6, 2023.
Yes I am aware of the update he is suppose to give, I also remeber he was presenting on a presentation and did not know current status of his tecnology. Look at what it takes to get on NASDAQ and to stay on it do you think Regen meets that , and can maintain the requirements?
Do you actually think that this will rebound and or hold multi dollars if split goes thru
Maybe we all should start filing a complaint against RGBP over the reason for R/S and that it will not do what Koos states and is fraud
https://www.sec.gov/oiea/Complaint.html
Not sure why
RGBPP
Regen Biopharma Inc (PK)
0.0085
0.0003 (3.66%)
Volume: 227,400
Day Range: 0.0081 - 0.0104
Bid: 0.0085
Ask: 0.0105
Last Trade Time: 11:25:52 AM EST
No comments since Nov 28 2022
No reply from Koos , I can see a lawsuit coming from this if he follows thru on R/S he is nowhere near the value he said he needed and Nasdaq requirements not met. Can't hold a penny and he thinks he will hold a 2-4 dollar range while trying to uplist to Nasdaq. No reason for R/S other than for him to dilute and give himself his shares back. No comment 29
Thank you , I thought I remember that statement from the video and it had a still of gold and a haystack, it has been awhile.
Sorry but if Lilly wants the technology, it would not matter what the share price or where it trades on the markets. The science is the science. 5 million to Lilly is nothing to fund without needing the company to trade on a higher tier platform. GLTA
Also still no reply from Koos, just as I thought it would be.Anyone else written and heard back?
As far as I know they did , also if you go back and listen to the Emerging growth Conference that started our downward spiral , Everything he laid out back in April 2021 was on a timeframe of 1 to 1 1/2 years. I believe they have been testing in EU for awhile along with Africa with Regeneron for awhile. Remember Regeneron does alot of headfakes claiming one thing and then they drop a bomb months before it was planned. IMO GLTA
I know this video was painful back in the day because he stated 1.5 years out , but now you listen and we are in that time frame and what has been happening is starting to showup. Give it a listen and see your take on it now. GLTA
https://emerginggrowth.com/emerging-growth-conference-5/
Okay here is the 1st time Needle in haystack was used by Enzolytics. It was the white paper with Intel . Just found it here is a copy of the exact wording, and now I know I saw that in that video they took down. Go to the white paper to see the full write up
https://finance.yahoo.com/news/enzolytics-inc-intel-corporation-co-110000244.html
Intel commends the discovery of Dr. Joseph Cotropia and Dr.Gaurav Chandra. Dr. Cotropia discovered a genetic amino acid sequence designated KLIC in the outer envelope of HIV. Discovering this sequence is like finding a "needle in a haystack" and retrieving the needle. These immutable sites have been identified and the antibody that targets those sites created. This antibody (Clone 3) can lock onto the KLIC epitope. Once bound by the antibody, the virus cannot infect a human cell and cannot ultimately reproduce.
GLTA
Does anyone remeber the video Enzolytics put out that seemed to be targeting researchers and development and then it was removed very quickly. I was having a flashback about the information that was discussed and I think I recall a statement and a still photo of a hay stack and a needle. Does anyone recall that that was able to see the video before it was taking down. Not trying to start rumors or anything but I think I recall that image from that video. I know there is a few longs here that caught that video any thoughts? GLTA
Thanks Falon
Alot has been done behind the scenes in 2022, and the EU results an approval will be here sooner than people are expecting. GLTA
Yeap they do drag their feet, nothing worse seeing the prices drop and you cant sell or buy. I would say everyone concerned about this R/S needs to send Koos their questions , concerns if SP doesnt hold what will be his plan and stress their displeasure, not that it will change but maybe. We can only hope it is canceled for now he should understand this was going to happen and his justification just went out the window, his SP will be much lower and will not gain the 4-5 price range he claims along with other requirements not being meet. What will his plan be now if R/S doesn't provide his estimate,that is what I am waiting on ( haha) but to carry thru on a R/S when it doesn't meet what he stated and knows ahead of time it won't, now that could be a fraud case. I think the shareholders could come together for a class action lawsuit. IMO
His best bet would be to cancel R/S releash info at end of month and hopefully we get a pump out of it and raise the price back in the .015 - .02 range. Setup a structured line of credit based off results, as positive results are disclosed more money can be released for further testing, if results or deadlines not met within reason the BP decides to walk away, steps in to provide assistance and a better structure payback based off % of future profits, or offers a buyout to complete the research and rights to products from that research. IMO. GLTA
What to keep in mind, he has claimed he is in talks ect, he has a relationship with Lilly, renouned doctors on his board yet no BP company will draft up anytype of deal for 5 million dollars to further research on ground breaking cancer techniques.
David.Koos@regenbiopharma.com
Question to David.Koos@regenbiopharma.com
I am an investor and would like to understand you are hoping to be at a 5 dollar share price time of the last EGC you were barely at 4.25 today you are at 2.66 and dropping. The shareholders are due better than this , a R/S is the worst thing right now not only are you not going to have the require SP but you have diluted all of the stock holders.
Please answer how the R/S is going to help now?
You do the R/S how are you going to raise the 5 million ?
Why isn’t a company you are working with do a 5 million funding based off results and future deals to be made they get back 7.5 million as payback for funding and then you proceed forward with license deals ect…
If you have the goods then some BP would fund 5 million and not blink at it why are they not jumping at a low cost investment?
What are you going to do when the SP is .0005 or lower then a R/S doesn’t do a damn thing .
So what is your plan come March 1st and SP is .0005 or lower?
You told us to write you our concerns here was a few
Here is a few posting on IHub . The stock holders are not in favor of this R/S and with our concerns and as you state you are doing it for shareholders. No your not and we don’t see it that way.
Thank you awaiting your reply
Koos needs a bare minimum SP pre RS 0f .0034 to meet the "5 Dollar demand" of institutions, but that will be shorted down quickly, so he has to hope for more like .007 at least, and then it won't even be long.
I just hope for good news about Dura or we are all screwed. (Or he cancels the RS)
As I showed earlier the company is not able to meet anything to get to any Nasdaq tiers, and currently the value is at 2.66 at current R/S plan not the 4 to 5 dollar he was flapping. The best thing he can do is cancel the R/S or do a buyout @ 1/2 billion get roughly .10 value and run off to retirement. If anyone has sent a question to Koo's and received any answers to them please post. I have not and didn't plan on getting a response due to the question being a simple and straight forward with no wiggle room for the answer. Hopefully they hype this one more time so some can at least get a little back. Lets just slam his email maybe he will get the hint to stop the R/S.
As I showed earlier the company is not able to meet anything to get to any Nasdaq tiers, and currently the value is at 2.66 at current R/S plan not the 4 to 5 dollar he was flapping. The best thing he can do is cancel the R/S or do a buyout @ 1/2 billion get roughly .10 value and run off to retirement. If anyone has sent a question to Koo's and recieved any answers to them please post. I have not and didn't plan on getting a response due to the question being a simple and straight forward with no wiggle room for the answer. Hopefully they hype this one more time so some can atleast get a little back. Lets just slam his email maybe he will get the hint to stop the R/S.
29 do you still thing he is great business man or just a great con man. Don't want to hear about the past, just the current situation. Why isnt Lilly or any other stepping up with an offer of 5 million to fund his needs. GLTA.
Understand that , I am talking about the the 250k needed and the approx 6 month time frame he was talking about at 25:42 in the call.. Also nothing is in clinical stage testing.Theoreticaly is used alot by Koos to plead his case he can get financing or attract BP because of the R/S. Theoreticaly most lenders look at how you will be paying back a loan and look to see you have a revenue stream which he states they don't but if they can licence then they would have revenue. I know you can't go to a bank and say I have a degree and I should be getting a job here soon and take out a car or mortgage on a house theoriticaly speaking.
The big issue is meeting requirements and standards not just a share price , Theoreticaly the companies starts out at a 5 dollar share price and then slowly and in most cases drops while this is going on. Theoreticaly the mm's are stocking up at this level and then drop it at the higher level just as they are currently while we the share holders lose share price value while waiting on uplisting.
https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/
We need a good pump within the next three weeks so alot can break even , make money or reduce loses that is better than the ones they are facing at theses prices. GLTA
I still say he allowed the stock to drop below the requirements for to long and is being removed or downgraded if he stays in the tier he currently is in. The pipdream to Nasdax is just that he has requirements to meet there , price, value, sales reveune for years , money on hand , ect.. He will not remain on any top tier platform for more than the time to drop below limits within weeks. He couldnt keep it here above a .01 ( penny ). Know you think that people wouldn't pay a penny will buy a 4 or 5 dollars.
Again his contacts, board members ect and they can't get a deal for 5 million , they can't pull 125k from the two in the interview ( Harry + Koos ) to finish testing which if is proven with good results then secure a 5 million buy in. All just crazy for a man that was hyped to be great. Bad timeing to say hey in a month doing a R/S . I and alot more I am sure would rather hold our shares stay in the .045 - .055 range than to be reduced in share count and then see the hypy value fall to the penny range in less then 2 weeks. I am sure a few of us would thru in 10k so 25 people 250k with a contract that when results are completed and funding is granted the ones who took a chance get 25 million shares each. He has given waymore away for alot less. More people who give the less it would be on us and then the amount of shares could be reduced to satisfied all parties . He has options out there if he thinks outside the box and work with his shareholders he so cares for. Just throwing out options GLTA and we need it at this point.
Thanks for proving the point he doesn't make the best decisions.
With the info over the past two years , the DD of the board , my 100k is on ENZC all in. GLTA
Call Koos and offer him a loan for 250k for 100 million shares , he loves making thoses deals
What was the stock
Just asking this and yes I want them to succeed. With filed patents and more in the pipeline as stated, why can't he raise 5 million from any BP espeacially the ones that so many times here pointed out working with ( Lilly ). Either Koos can't BS the big boys or the products are not what they appear or further out than we have been lead to believe . I hope I am wrong , but if you or anyone else can explain why BP isn't stepping up with 5 million I would like to hear that. They stated yesterday 250k to get a few more test results was needed and a time line roughly 2 months, and 5 million to fund whatever else for awhile. BP would make an agreement for 5 million to see results within a described timeline. Then RGBP retires shares without R/S moves to a new trading platform and either holds the share price they would be at or not. BP either has a new partner or is out of 5 million. Very little downside for BP and RGBP either is on the big stage from there on out or they fade away. IMO GLTA
That was one of many question I sent in to the EGC today. He needs to come out with good news along with saying if the share price is better he will restructure the R/S. Again a BP wont step up to fund a 5 million request . Where is Lilly ? I hope people are seeing who we are not hearing from. GLTA
Alzasa0f sorry don't have private message . I don't see much happening either direction unless the mm's want one last run . I see the same trading pattern until the R/S happens. I think alot are in here @.02 range and are stuck. At .02 average say you have 4 million shares you have 80k invested. R/S happens 2666 shares now you need a 30.00 per share to break even. Alot to ask for anytime soon not that it can't happen. I just can't see a BP not stepping in for a partial buy in for the low price he is thinking he needes really 5 million. BP could make a deal with him for 25 million and not even blink an eye. Easy to do the math and see your position and see what you are comfortable with. IMO GLTA